Apogee Therapeutics (APGE) News Today $44.48 +2.62 (+6.26%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$44.11 -0.37 (-0.83%) As of 06/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APGE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Apogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Recommendation of "Buy" by BrokeragesApogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) has been given an average recommendation of "Buy" by the five ratings firms that are currently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a buy rating. The average 1-year price target among brokers tJune 16 at 3:08 AM | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Shares Up 5.3% - What's Next?Apogee Therapeutics (NASDAQ:APGE) Shares Up 5.3% - Time to Buy?June 13 at 2:47 PM | marketbeat.comCarl Dambkowski Sells 2,725 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) StockApogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 2,725 shares of the business's stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $36.96, for a total transaction of $100,716.00. Following the completion of the transaction, the insider now owns 241,723 shares of the company's stock, valued at approximately $8,934,082.08. This trade represents a 1.11% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.June 6, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Trading Up 8.8% - Here's WhyApogee Therapeutics (NASDAQ:APGE) Trading Up 8.8% - Should You Buy?June 6, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $6.52 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquireJune 1, 2025 | marketbeat.comSquarepoint Ops LLC Buys 17,301 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)Squarepoint Ops LLC lifted its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 90.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,344 shares of the company's stock after purchaMay 31, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Bank of America Corp DEBank of America Corp DE reduced its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 64.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 105,540 shares of the company's stock after selling 193,932 shares dMay 30, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Shares Down 3% - Here's WhyApogee Therapeutics (NASDAQ:APGE) Shares Down 3% - Time to Sell?May 29, 2025 | marketbeat.comApogee Therapeutics to Participate at the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comMillennium Management LLC Has $5.90 Million Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Millennium Management LLC increased its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 44.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 130,171 shares of the company's stock after purchasinMay 29, 2025 | marketbeat.comTwo Sigma Advisers LP Has $3.24 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Two Sigma Advisers LP increased its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 51.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,500 shares of the company's stockMay 28, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $445,000 Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)D. E. Shaw & Co. Inc. trimmed its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 80.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,813 shares of the company's stock afteMay 28, 2025 | marketbeat.comNeo Ivy Capital Management Acquires New Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Neo Ivy Capital Management bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 38,523 shares of the company's stock, valued at approximately $1,745,000. Neo Ivy Capital MMay 26, 2025 | marketbeat.comTwo Sigma Investments LP Increases Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Two Sigma Investments LP lifted its position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 33.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 266,482 shares of the company's stock after buying an additional 67,174 shares duringMay 26, 2025 | marketbeat.comDeutsche Bank AG Boosts Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Deutsche Bank AG raised its position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 50.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,739 shares of the company's stock after purchasing an additional 10,709 shaMay 26, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Given Average Rating of "Buy" by BrokeragesShares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Get Free Report) have received an average recommendation of "Buy" from the five analysts that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12 month pMay 24, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Woodline Partners LPWoodline Partners LP grew its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,015,608 shares of the company's stock after buying an additional 39,May 22, 2025 | marketbeat.comSoleus Capital Management L.P. Invests $3.17 Million in Apogee Therapeutics, Inc. (NASDAQ:APGE)Soleus Capital Management L.P. bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 70,000 shares of the company's stock, valued at approximately $3May 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Lowers Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Point72 Asset Management L.P. reduced its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 57.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 302,735 shares of the companMay 20, 2025 | marketbeat.comNorthern Trust Corp Grows Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Northern Trust Corp increased its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 6.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 327,292 shares of the company's stock after purchaMay 18, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Paradigm Biocapital Advisors LPParadigm Biocapital Advisors LP raised its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 82.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,283,766May 16, 2025 | marketbeat.comParkman Healthcare Partners LLC Buys Shares of 85,000 Apogee Therapeutics, Inc. (NASDAQ:APGE)Parkman Healthcare Partners LLC bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 85,000 shares of the company's stock, valueMay 16, 2025 | marketbeat.comWedbush Research Analysts Boost Earnings Estimates for APGEApogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Analysts at Wedbush increased their Q2 2025 earnings per share estimates for shares of Apogee Therapeutics in a note issued to investors on Monday, May 12th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings oMay 16, 2025 | marketbeat.comJanus Henderson Group PLC Buys 665,543 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE)Janus Henderson Group PLC grew its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 141.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,135,100 shares of the company's stock after acMay 16, 2025 | marketbeat.comEquities Analysts Offer Predictions for APGE Q1 EarningsApogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) - Investment analysts at Wedbush issued their Q1 2026 earnings estimates for shares of Apogee Therapeutics in a research report issued to clients and investors on Monday, May 12th. Wedbush analyst D. Nierengarten expects that the company willMay 15, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Holdings Cut by Comerica BankComerica Bank trimmed its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 26.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,540 shares of the company's stock after selling 7,518 shares duriMay 15, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Issues Quarterly Earnings Results, Beats Expectations By $0.24 EPSApogee Therapeutics (NASDAQ:APGE - Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.95) EPS for the quarter, beating the consensus estimate of ($1.19) by $0.24.May 14, 2025 | marketbeat.comJefferies Financial Group Inc. Boosts Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Jefferies Financial Group Inc. increased its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 140.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 887,497 shares of the company's stock after purchasing anMay 13, 2025 | marketbeat.comWhy Is Apogee Therapeutics Stock Trading Higher On Monday?May 13, 2025 | finance.yahoo.comApogee Therapeutics: APG808 Asthma Treatment May Overtake Dupixent In IL-4Rα ClassMay 13, 2025 | seekingalpha.comApogee Therapeutics reports positive results from asthma treatment trialMay 13, 2025 | msn.comApogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial ResultsMay 12, 2025 | globenewswire.comApogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate AsthmaMay 12, 2025 | globenewswire.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Frontier Capital Management Co. LLCFrontier Capital Management Co. LLC reduced its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 44.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 172,711 shares of the company's stock afMay 12, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $4.13 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)Cubist Systematic Strategies LLC lifted its holdings in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,213 shares of the company's stock after purcMay 12, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Has $3.98 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)The Manufacturers Life Insurance Company raised its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 29.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 87,953 shares of the company's stock after buying anMay 11, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Bought by Driehaus Capital Management LLCDriehaus Capital Management LLC lifted its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 2.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,605,310 shares of the company's sMay 10, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Shares Sold by Braidwell LPBraidwell LP reduced its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 6.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,540,362 shares of the company's stock after selling 102,864 shares during theMay 8, 2025 | marketbeat.comApogee Therapeutics (APGE) to Release Quarterly Earnings on MondayApogee Therapeutics (NASDAQ:APGE) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-apogee-therapeutics-inc-stock/)May 7, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Purchases Shares of 70,766 Apogee Therapeutics, Inc. (NASDAQ:APGE)Schonfeld Strategic Advisors LLC acquired a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 70,766 shares of the company's stock, valued at approximately $3May 6, 2025 | marketbeat.comVoya Investment Management LLC Decreases Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Voya Investment Management LLC cut its holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,960 shares of the company's stock after selling 10,557 sMay 6, 2025 | marketbeat.comAllostery Investments LP Takes $4.53 Million Position in Apogee Therapeutics, Inc. (NASDAQ:APGE)Allostery Investments LP bought a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 100,000 shares of the company's stock, valued at approximately $4,530,0May 4, 2025 | marketbeat.com86,000 Shares in Apogee Therapeutics, Inc. (NASDAQ:APGE) Purchased by Boxer Capital Management LLCBoxer Capital Management LLC acquired a new stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 86,000 shares of the company's stock, valued atMay 4, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Makes New Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)Mercer Global Advisors Inc. ADV acquired a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 720,101 shares of the company's stock, valued at appMay 4, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Holdings Lowered by Invesco Ltd.Invesco Ltd. lowered its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 83.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,256 shares of the company's stock after selling 110,9May 4, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Stock Holdings Decreased by RA Capital Management L.P.RA Capital Management L.P. lessened its position in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,569,491 shares of the company's stock after selling 392,372 shaMay 3, 2025 | marketbeat.comApogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's WhyApogee Therapeutics (NASDAQ:APGE) Hits New 1-Year High - Here's What HappenedMay 3, 2025 | marketbeat.comWells Fargo & Company MN Lowers Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE)Wells Fargo & Company MN lowered its stake in Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 82.0% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,705 shares of the company's stock after selling 80,585 shares durMay 3, 2025 | marketbeat.comApogee Therapeutics, Inc. (NASDAQ:APGE) Stock Position Boosted by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD raised its stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE - Free Report) by 38.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,052,595 shares of the company's sMay 2, 2025 | marketbeat.comApogee Therapeutics to Participate at the Bank of America 2025 Health Care ConferenceMay 1, 2025 | globenewswire.com Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address APGE Media Mentions By Week APGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APGE News Sentiment▼1.340.90▲Average Medical News Sentiment APGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APGE Articles This Week▼24▲APGE Articles Average Week Get Apogee Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELAN News Today VRNA News Today LEGN News Today TGTX News Today GRFS News Today LNTH News Today TLX News Today NUVL News Today AXSM News Today ADMA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APGE) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apogee Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apogee Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
